Texas Tech University Health Sciences Center, El Paso
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Texas Tech University Health Sciences Center, El Paso sits in the top decile of US sponsors by registered trial count (#473 of 15,742 sponsors by registered trial count).
Texas Tech University Health Sciences Center, El Paso: 35 sponsored US clinical trials, 3 recruiting.
Texas Tech University Health Sciences Center, El Paso sponsors 35 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 21 completed. 4 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Operative Time, with 1 trials.
Top-decile sponsor footprint
Texas Tech University Health Sciences Center, El Paso ranks in the top decile of sponsors by registered trial count (#473 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 31 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (67.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
35 total, page 1 of 1
Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients
NCT07561541
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
NCT06016465
Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
NCT04646083
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
NCT03119584
Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms?
NCT05303116
Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles
NCT05174988
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
NCT05077917
Surgical Management of Knee Septic Arthritis
NCT04786379
CCM Blood Biomarker Validation Study
NCT05148663
Utilizing Telemedicine for Delivery of Postoperative Care
NCT04348357
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
NCT05153278
With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care
NCT03736031
Impact of Fascia Iliaca Block in Hip Fracture Patients
NCT03525977
Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.
NCT03264092
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques
NCT03144180
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
NCT03125811
A Prospective Study of Diagnostic Accuracy of Ultrasound
NCT03120078
El Paso Public Health Biorepository
NCT03123705
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
NCT03144037
Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
NCT03123263
Effect of Simethicone on Screening Colonoscopy
NCT03119168
Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis
NCT03123809
Glyburide vs Glucovance in the Treatment of GDM
NCT02726490
Neoadjuvant Propanolol in Breast Cancer
NCT02596867
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
NCT02017379
The Utility of Timed Segmental Withdrawal During Screening Colonoscopy
NCT02132455
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
NCT01916460
The Cellularity Yield of Three Different 22-gauge FNA Needles
NCT01916421
Continuous Femoral and Tibial Nerve Blocks in TKA Patients
NCT01680692
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
NCT01673269
Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation
NCT01469819
The Utility of Cap Colonoscopy in Increasing Adenoma Detection Rate
NCT01601431
Lubiprostone and Mucus Secretion in Patients With Chronic Constipation
NCT01447849
Comparison Between Two Methods of Spontaneous Breathing Trial (SBT)
NCT00400881
Estimation of Intrinsic Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome (ARDS)
NCT00446706
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the Texas Tech University Health Sciences Center, El Paso pipeline
3 recruiting of 35 indexed (9% open); 21 completed (60%).
Phase mix: 4 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Operative Time (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas Tech University Health Sciences Center, El Paso: open-pipeline peers nationwide
Peers matched on 35 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Texas Tech University Health Sciences Center, El Paso sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 35 trials (± recruiting share)
- ACADIA Pharmaceuticals · 35 trials · 9% recruiting
- INSYS Therapeutics · 35 trials · 0% recruiting
- Merz North America · 35 trials · 3% recruiting
- Palo Alto Veterans Institute for Research · 35 trials · 20% recruiting
Sponsors near 9% open enrollment (± trial volume)
- National Institute of Neurological Disorders and Stroke (NINDS) · 8% recruiting · 567 trials
- AMAG Pharmaceuticals · 9% recruiting · 23 trials
- Iowa State University · 9% recruiting · 23 trials
- New Approaches to Neuroblastoma Therapy Consortium · 9% recruiting · 23 trials
Related
What to do with this Texas Tech University Health Sciences Center, El Paso page
35 registered trials is a research-attention snapshot, not an endorsement of Texas Tech University Health Sciences Center, El Paso or any single study.
- 3 of Texas Tech University Health Sciences Center, El Paso's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Operative Time is the condition Texas Tech University Health Sciences Center, El Paso studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Operative Time trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas Tech University Health Sciences Center, El Paso pipeline card: 35 registered trials from official public datasets.Report a data error.